WallStreetZenWallStreetZen

NASDAQ: LUNG
Pulmonx Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LUNG past revenue growth

How has LUNG's revenue growth performed historically?
Company
27.98%
Industry
9.47%
Market
17.2%
LUNG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LUNG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LUNG's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LUNG earnings and revenue history

Current Revenue
$68.7M
Current Earnings
-$60.8M
Current Profit Margin
-88.6%

LUNG Return on Equity

Current Company
-46.6%
Current Industry
10.5%
Current Market
188%
LUNG's Return on Equity (-46.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LUNG announces earnings.

LUNG Return on Assets

Current Company
-32.1%
Current Industry
5.3%
LUNG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LUNG Return on Capital Employed

Current Company
-36.89%
Current Industry
8.3%
LUNG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LUNG vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LUNG$68.68M-$52.81M-$60.84M+27.98%N/A
AXGN$159.01M-$13.33M-$21.72M+13.63%N/A
TLIS$2.13M-$56.93M-$62.01M-2.24%N/A
TLSI$18.51M-$58.31M-$59.04M+48.44%N/A
CVRX$39.30M-$38.73M-$41.20M+58.30%N/A
View Top Medical Device Stocks

LUNG earnings dates

Next earnings date
May 16, 2024

Pulmonx Earnings & Revenue FAQ

What were LUNG's earnings last quarter?

On Invalid Date, Pulmonx (NASDAQ: LUNG) reported Q4 2023 earnings per share (EPS) of -$0.36, up 5.26% year over year. Total Pulmonx earnings for the quarter were -$13.89 million. In the same quarter last year, Pulmonx's earnings per share (EPS) was -$0.38.

If you're new to stock investing, here's how to buy Pulmonx stock.

What was LUNG's earnings growth in the past year?

As of Q2 2024, Pulmonx's earnings has grown year over year. Pulmonx's earnings in the past year totalled -$60.84 million.

What is LUNG's earnings date?

Pulmonx's earnings date is Invalid Date. Add LUNG to your watchlist to be reminded of LUNG's next earnings announcement.

What was LUNG's revenue last quarter?

On Invalid Date, Pulmonx (NASDAQ: LUNG) reported Q4 2023 revenue of $19.28 million up 24.98% year over year. In the same quarter last year, Pulmonx's revenue was $15.43 million.

What was LUNG's revenue growth in the past year?

As of Q2 2024, Pulmonx's revenue has grown 27.98% year over year. This is 18.51 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Pulmonx's revenue in the past year totalled $68.68 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.